Key clinical point: Among patients with COPD and OSA, lung function and CPAP use are independent predictors of COPD exacerbations and all‐cause mortality.
Major finding: The average time of CPAP use was significantly higher in patients with no recorded exacerbation: 285.4 min/night vs. 238.2 min/night.
Study details: A retrospective cohort study that included 92 patients with overlap syndrome who had a COPD exacerbation and 92 patients with overlap who did not.
Disclosures: The authors had no conflicts of interest.
Jaoude P et al. Clin Respir J. 2019 Aug 22. doi: 10.1111/crj.13079.
Must Reads in Pulmonology
Electronically Delivered Interventions in Antibiotic Rx, BMJ; ePub 2019 Feb 13; Gulliford, et al
Physician Care for Patients with COPD, CHEST; ePub 2019 Jan 18; Cho, Mecredy, et al
Venous Thromboembolism Risk in US Hospitals, Am J Med; ePub 2019 Jan 16; Huang, et al
Prescribed Opioids & Risk of CAP in Patients with HIV, JAMA Intern Med; 2019 Jan 7; Edelman, et al